FDA Firewall Statistician does not work for nor is that person part of the FDA, seems to be what ohm is saying. And maybe the FDA Firewall Statistician has the unblinded data, or guards it, but does not look at it, does not analyze it, and could not "use it" to justify or ask for the FDA to grant any type of access to leronlimab. But some comment recently just mentioned that there is a committee that consistently looks at SAEs and AEs (and thus deaths), to continually monitor all clinical trials, to protect involved humans receiving treatment, and this committee has the authority to halt any trial, pending their observations and concerns.